Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Asness’ Secret Formula Points To Apple, Microsoft, and Pfizer

Page 1 of 2

AQR Capital Management is predominantly a quantitative equity hedge fund firm, co-founded by former Goldman Sachs portfolio manager Clifford S. Asness in 1997. Nevertheless, this investment management firm focuses on other traditional investing approaches as well. Clifford Asness is well-known for founding one of the earliest “quant vehicles” within Goldman Sachs, called the Global Alpha fund, which was later headed by Mark Carhart. Global Alpha had grown from $100 million under management to $7 billion in its first three years, while the record return reached a figure of more than 100% after fees. AQR (which stands for “Applied Quantitative Research”) Capital Management, which is one of the top hedge funds in the world when considering total assets under management, has applied mathematics to market data and made evidence-based investments across different asset classes quite successfully. Asness’ flagship Absolute Return Fund, which is the successor of Global Alpha, has generated an annualized return of 10.8% net-of-fees despite suffering destructive losses during the financial crisis of 2008 (note: the annualized return includes the three-year returns of Global Alpha). In this article we will cover three top picks of this hedge fund, identified by Asness’ and his team’s quant strategies, that include the following companies: Apple Inc. (NASDAQ:AAPL), Microsoft Corporation (NASDAQ:MSFT) and Pfizer Inc. (NYSE:PFE). As AQR is a quant hedge fund, that means these aren’t discretionary stock picks. AQR’s mathematical algorithms have been sending “undervalued” signals for these stocks. Apple and Pfizer have consistently been among AQR’s top picks but in the first quarter,  Microsoft also managed to get into this group, with AQR upping its position by 42%.


Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 144% over the ensuing 32 months, outperforming the S&P 500 Index by 84 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody. There are only a few hedge fund managers -quant hedge funds are disproportionally represented in this group- who can outperform the market by picking large-cap picks.

Cliff Asness
Cliff Asness
AQR Capital Management

AQR Capital increased its equity stake in Apple Inc. (NASDAQ:AAPL) by 529,740 shares during the most recent quarter. This move augmented the hedge fund’s overall position in the most valuable publicly-traded company in the world to 6.89 million shares, which are valued at $857.71 million as of March 31, 2015. One of the most captivating rumors that has been circulating around Apple is that the company intends to launch self-healing screens for new iPhones in upcoming years. This will undoubtedly boost the revenue generated from iPhones and assist the company in growing even bigger, since cracked phone screens happen far too often. Supposedly, Apple has already developed a chemical process that allows glass phone screens to heal themselves of imperfections. In the meantime, the company’s stock has risen by over 14% year-to-date. Activist investor Carl Icahn, who manages Icahn Capital, is by far the largest shareholder within our database in Apple Inc. (NASDAQ:AAPL), owning 52.76 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!